Information Provided By:
Fly News Breaks for July 10, 2017
DBD, NCR
Jul 10, 2017 | 06:00 EDT
JPMorgan analyst Paul Coster recommends buying both NCR Corp. (NCR) and Diebold (DBD) on the recent weakness caused by Diebold's negative preannouncement last week. After speaking to both managements, the analyst concludes that the companies are experiencing "largely uninterrupted" demand for ATMs, retail self-checkout terminals and for software-based omni-channel solutions. The analyst prefers NCR to Diebold and keeps Overweight ratings on both names.
News For NCR;DBD From the Last 2 Days
DBD
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.